Free shipping on all orders over $ 500

 About 11 results found for searched term "67-71-0" (0.126 seconds)

Cat.No.  Name Target
M14387 Dimethyl sulfone Metabolite/Endogenous Metabolite
Dimethyl sulfone is an endogenous metabolite.
M29855 dCeMM2  PROTAC
dCeMM2 (Compound 2) is a glue degrader. dCeMM2 induces ubiquitination and degradation of cyclin K by prompting an interaction of CDK12-cyclin K with a CRL4B ligase complex.
M51969 3, 5-Diiodo-D-tyrosine Amino Acid Derivatives
3,5-Diiodo-D-tyrosine is a tyrosine derivative.
M56101 RS 39604  5-HT Receptor
RS 39604 is a potent, selective, and orally active 5-HT4 receptor antagonist with a pKi of 9.1 in guinea pig striatal membranes.
M2050 GSK2636771 PI3K
GSK2636771 is a potent, orally available and specific PI3K p110β (PI3K beta, PI3Kβ) inhibitor.
M2271 PF-4708671 S6 Kinase
PF-04708671
PF-4708671 is a novel cell-permeable inhibitor of S6K1 with Ki/IC50 value of 20 nM/160 nM. PF4708671 inhibits MSK1 (IC50 of 0.95 μM) 4-fold more weakly than S6K1.
M20981 BI-671800 Prostaglandin Receptor
AP-761, Cmpd A
BI-671800 (AP-761, Cmpd A) is a highly specific and potent antagonist of chemoattractant receptor-homologous molecule on Th2 cells (DP2/CRTH2) with IC50 of 4.5 nM and 3.7 nM for PGD2 binding to human CRTH2 and murine CRTH2, respectively. BI-671800 is associated with a small improvement in FEV1 in symptomatic controller-naïve asthma patients, and in patients on ICS.
M28479 VU0467485 AChR/AChE
AZ13713945
VU0467485 (AZ13713945) is a potent, selective, and orally bioavailable muscarinic acetylcholine receptor 4 (M4) positive allosteric modulator (PAM). VU0467485 (AZ13713945) potentiates activity of ACh at M4 with EC50s of 26.6 nM and 78.8 nM at rat and human M4 receptors, respectively. VU0467485 (AZ13713945) shows selectivity for M4 over human and rat M1/2/3/5. VU0467485 (AZ13713945) displays moderate to high CNS penetration. VU0467485 (AZ13713945) has antipsychotic-like activity.
M28634 PF-06648671  Gamma-secretase/Beta-secretase
PF-06648671 is a novel, brain-penetrable, and orally active γ-secretase modulator (GSM). PF-06648671 reduces Aβ42 and Aβ40, with concomitant increases in Aβ37 and Aβ38 in vitro. PF-06648671 is used for the study of Alzheimer’s disease.
M29167 PF-06795071  MAGL
PF-06795071 is a potent and selective covalent MAGL inhibitor with an IC50 of 3 nM.
M52427 β-Secretase inhibitor Gamma-secretase/Beta-secretase
β-Secretase inhibitor ([Asn670, Sta671, Val672]-Amyloid β Peptide (662-675)) is a β-secretase and BACE1 inhibitor (IC50: 25 nM for β-secretase).



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.